Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan to Prevent Sickle Cell Kidney Disease
NCT02373241Phase 2Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2015
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in hypertension (HTN), Kidney disease, proteinuria, sponsored by University of Alabama at Birmingham. Started Apr 2015; status: terminated.
02
Drugs
losartan
03
Conditions
hypertension (HTN)Kidney diseaseproteinuria
Beyond the preview
Go deeper on NCT02373241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02373241.